Cite
The radioenhancement of two human head and neck squamous cell carcinomas by 2'-2' difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs.
MLA
Rosier, Jean-François, et al. “The Radioenhancement of Two Human Head and Neck Squamous Cell Carcinomas by 2’-2’ Difluorodeoxycytidine (Gemcitabine; DFdC) Is Mediated by an Increase in Radiation-Induced Residual Chromosome Aberrations but Not Residual DNA DSBs.” Mutation Research, vol. 527, no. 1–2, June 2003, pp. 15–26. EBSCOhost, https://doi.org/10.1016/s0027-5107(03)00053-8.
APA
Rosier, J.-F., Michaux, L., Ameye, G., Cedervall, B., Libouton, J.-M., Octave-Prignot, M., Verellen-Dumoulin, C., Scalliet, P., & Grégoire, V. (2003). The radioenhancement of two human head and neck squamous cell carcinomas by 2’-2’ difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs. Mutation Research, 527(1–2), 15–26. https://doi.org/10.1016/s0027-5107(03)00053-8
Chicago
Rosier, Jean-François, Lucienne Michaux, Geneviève Ameye, Björn Cedervall, Jeanne-Marie Libouton, Michèle Octave-Prignot, Christine Verellen-Dumoulin, Pierre Scalliet, and Vincent Grégoire. 2003. “The Radioenhancement of Two Human Head and Neck Squamous Cell Carcinomas by 2’-2’ Difluorodeoxycytidine (Gemcitabine; DFdC) Is Mediated by an Increase in Radiation-Induced Residual Chromosome Aberrations but Not Residual DNA DSBs.” Mutation Research 527 (1–2): 15–26. doi:10.1016/s0027-5107(03)00053-8.